Risankizumab for Fibrostenotic Crohn's Disease Treatment
Risankizumab for Fibrostenotic Crohn's Disease Treatment
Not yet recruiting · NCT07177118 · Registry updated 2025-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Risankizumab for Fibrostenotic Crohn's Disease Treatment | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 3 | 2025-09-16 | NCT07177118 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| First Affiliated Hospital of Wenzhou Medical University | 117 |
| Second Affiliated Hospital of Wenzhou Medical University | 81 |
| Taizhou Hospital | 28 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||